Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Mirabel Meds vs Spry

Mirabel Meds
Graded #396

Higher grade

vs+0.7000000000000028
Spry
Graded #408

Lower grade

The verdict

Mirabel Meds takes it — 57.5/100 to 56.8/100, but only just.

Mirabel Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mirabel Meds is a LegitScript-certified telehealth clinic headquartered in West Palm Beach, FL offering compounded semaglutide, tirzepatide, and GLP-1 microdose injections with a white-glove concierge model. Spry is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueSpry +9
45
54
Dose & formulationSpry +24
40
64
Clinical oversightMirabel Meds +24
79
55
Labs & monitoringMirabel Meds +2
54
52
FulfillmentMirabel Meds +22
83
61
Contract termsEven
55
55
Mirabel Meds · left barSpry · right bar

The numbers

MetricMirabel MedsSpry
WeighScore57.5/10056.8/100
GradeCC
Scorecard rank#396#408
SemaglutideNot disclosed$199/mo (starting dose, compounded)
TirzepatideNot disclosed$299/mo (starting dose, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Mirabel Meds

Graded #396 · C

Strengths

  • LegitScript certified with board-certified Internal Medicine physician oversight
  • Compounded semaglutide, tirzepatide, and GLP-1 microdose injection options
  • White-glove concierge — direct provider messaging, no automated bots
  • Cold-chain temperature-controlled delivery to all 50 states
  • Monthly clinical reviews and dose adjustments included with every plan

Where it loses points

  • Pricing not publicly disclosed — requires a consultation to receive a quote
  • Compounded medications are not FDA-approved individual drugs
  • No named pharmacy partner disclosed on public pages
  • Labs not mentioned on any public page — baseline bloodwork protocol unknown
  • Concierge positioning suggests premium pricing above market average
Spry

Graded #408 · C

Strengths

  • Three named co-founders disclosed (Gabriel Mullins, Sara Yoder, Tyler Bowman) — better-than-average transparency
  • Pricing shown on the homepage ($199 semaglutide / $299 tirzepatide / $249–$299 peptides) — no full sign-up wall
  • Broader range (2 GLP-1s plus 3 anti-aging peptides) appeals to longevity buyers
  • No contracts or commitment required
  • LegitScript Certified with a public verification link

Where it loses points

  • Displays an "FDA Approved" badge though compounded GLP-1s are not FDA-approved finished drugs — potentially misleading
  • Intake reviewed by a nurse practitioner, not an MD
  • States served not disclosed publicly
  • Pharmacy partner not named, and 503A vs 503B designation not specified
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard